Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2020

Ausgabe 1/2020

Inhaltsverzeichnis ( 26 Artikel )

01.01.2020 | Editorial | Ausgabe 1/2020


Bill Gradishar

14.09.2019 | Preclinical study | Ausgabe 1/2020 Open Access

Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort

Angela S. Cheng, Samuel C. Y. Leung, Dongxia Gao, Samantha Burugu, Meenakshi Anurag, Matthew J. Ellis, Torsten O. Nielsen

16.09.2019 | Preclinical study | Ausgabe 1/2020

Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy

Clémence Pinard, Marc Debled, Houda Ben Rejeb, Valérie Velasco, Christine Tunon de Lara, Stéphanie Hoppe, Elodie Richard, Véronique Brouste, Hervé Bonnefoi, Gaëtan MacGrogan

17.09.2019 | Preclinical study | Ausgabe 1/2020

High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer

Mikhail Gorbounov, Neil M. Carleton, Rebecca J. Asch-Kendrick, Lingling Xian, Lisa Rooper, Lionel Chia, Ashley Cimino-Mathews, Leslie Cope, Alan Meeker, Vered Stearns, Robert W. Veltri, Young Kyung Bae, Linda M. S. Resar

18.09.2019 | Preclinical study | Ausgabe 1/2020 Open Access

The intra-tumoural stroma in patients with breast cancer increases with age

Kiki M. H. Vangangelt, Claire J. H. Kramer, Esther Bastiaannet, Hein Putter, Danielle Cohen, Gabi W. van Pelt, Emad A. Rakha, Andrew R. Green, Rob A. E. M. Tollenaar, Wilma E. Mesker

19.09.2019 | Preclinical Study | Ausgabe 1/2020

COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells

Naoise C. Synnott, David O’Connell, John Crown, Michael J. Duffy

21.09.2019 | Preclinical study | Ausgabe 1/2020

Prevalence and scope of advanced practice provider oncology care among Medicare beneficiaries with breast cancer

Tina W. F. Yen, Purushottam W. Laud, Emily L. McGinley, Liliana E. Pezzin, Ann B. Nattinger

27.09.2019 | Preclinical study | Ausgabe 1/2020 Open Access

Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy

Suzanne E. Wardell, Alexander P. Yllanes, Christina A. Chao, Yeeun Bae, Kaitlyn J. Andreano, Taylor K. Desautels, Kendall A. Heetderks, Jeremy T. Blitzer, John D. Norris, Donald P. McDonnell

10.10.2019 | Preclinical study | Ausgabe 1/2020 Open Access

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer

Abrar I. Aljohani, Michael S. Toss, Sasagu Kurozumi, Chitra Joseph, Mohammed A. Aleskandarany, Islam M. Miligy, Rokaya El Ansari, Nigel P. Mongan, Ian O. Ellis, Andrew R. Green, Emad A. Rakha

18.09.2019 | Clinical trial | Ausgabe 1/2020

Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors

Mitsuo Terada, Akiyo Yoshimura, Masataka Sawaki, Masaya Hattori, Gondo Naomi, Haruru Kotani, Yayoi Adachi, Madoka Iwase, Ayumi Kataoka, Kayoko Sugino, Makiko Mori, Nanae Horisawa, Yuri Ozaki, Hiroji Iwata

18.09.2019 | Clinical trial | Ausgabe 1/2020

Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience

Nicolò Matteo Luca Battisti, Victoria True, Narda Chaabouni, Neha Chopra, Karla Lee, Scott Shepherd, Tal Shapira-Rotenberg, Rashi Joshi, Sophie McGrath, Alicia Okines, Marina Parton, Nicholas Turner, Kabir Mohammed, Mark Allen, Stephen Johnston, Alistair Ring

20.09.2019 | Clinical trial | Ausgabe 1/2020

A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases

José Pablo Leone, Dan G. Duda, Jiani Hu, William T. Barry, Lorenzo Trippa, Elizabeth R. Gerstner, Rakesh K. Jain, Sally Tan, Elizabeth Lawler, Eric P. Winer, Nancy U. Lin, Sara M. Tolaney

20.09.2019 | Clinical trial | Ausgabe 1/2020

Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies

Jungeun Jeon, Sung Eun Kim, Dong-Yun Lee, DooSeok Choi

21.09.2019 | Clinical trial | Ausgabe 1/2020 Open Access

Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up

Joost A. G. N. Wolfs, Luuke G. E. H. de Joode, René R. W. J. van der Hulst, Shan S. Qiu

08.10.2019 | Clinical trial | Ausgabe 1/2020

Long-term prognostic effect of hormone receptor subtype on breast cancer

Ki-Tae Hwang, Jongjin Kim, Jiwoong Jung, Byoung Hyuck Kim, Jeong Hwan Park, Sook Young Jeon, Kyu Ri Hwang, Eun Youn Roh, Jin Hyun Park, Su-jin Kim

09.10.2019 | Clinical trial | Ausgabe 1/2020

Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors

Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, Khalil Zaman, Olivier Lamy

11.10.2019 | Clinical trial | Ausgabe 1/2020

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials

Evandro de Azambuja, Noam Ponde, Marion Procter, Priya Rastogi, Reena S. Cecchini, Matteo Lambertini, Karla Ballman, Alvaro Moreno Aspitia, Dimitrios Zardavas, Lise Roca, Richard D. Gelber, Martine Piccart-Gebhart, Thomas Suter

11.10.2019 | Clinical trial | Ausgabe 1/2020

Effect of progressive resistance training on persistent pain after axillary dissection in breast cancer: a randomized controlled trial

Gunn Ammitzbøll, Kenneth Geving Andersen, Pernille Envold Bidstrup, Christoffer Johansen, Charlotte Lanng, Niels Kroman, Bo Zerahn, Ole Hyldegaard, Elisabeth Wreford Andersen, Susanne Oksbjerg Dalton

18.09.2019 | Epidemiology | Ausgabe 1/2020 Open Access

Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications

Emma H. Allott, Yue Shan, Mengjie Chen, Xuezheng Sun, Susana Garcia-Recio, Erin L. Kirk, Andrew F. Olshan, Joseph Geradts, H. Shelton Earp, Lisa A. Carey, Charles M. Perou, Ruth M. Pfeiffer, William F. Anderson, Melissa A. Troester

21.09.2019 | Epidemiology | Ausgabe 1/2020 Open Access

Research-based PAM50 signature and long-term breast cancer survival

Minya Pu, Karen Messer, Sherri R. Davies, Tammi L. Vickery, Emily Pittman, Barbara A. Parker, Matthew J. Ellis, Shirley W. Flatt, Catherine R. Marinac, Sandahl H. Nelson, Elaine R. Mardis, John P. Pierce, Loki Natarajan

25.09.2019 | Epidemiology | Ausgabe 1/2020

Racial differences in employment and cost-management behaviors in patients with metastatic breast cancer

Cleo A. Samuel, Jennifer C. Spencer, Donald L. Rosenstein, Katherine E. Reeder-Hayes, Michelle L. Manning, Jean B. Sellers, Stephanie B. Wheeler

01.10.2019 | Epidemiology | Ausgabe 1/2020

Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada

Phillip S. Blanchette, Melody Lam, Lucie Richard, Britney Allen, Salimah Z. Shariff, Ted Vandenberg, Kathleen I. Pritchard, Kelvin K. W. Chan, Alexander V. Louie, Danielle Desautels, Jacques Raphael, Craig C. Earle

10.10.2019 | Epidemiology | Ausgabe 1/2020

Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study

Zaixing Shi, Andrew Rundle, Jeanine M. Genkinger, Ying Kuen Cheung, Isaac J. Ergas, Janise M. Roh, Lawrence H. Kushi, Marilyn L. Kwan, Heather Greenlee

30.09.2019 | Brief Report | Ausgabe 1/2020

Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues

John R. Hawse, Jodi M. Carter, Kirsten G. M. Aspros, Elizabeth S. Bruinsma, Justin W. Koepplin, Vivian Negron, Malayannan Subramaniam, James N. Ingle, Karen L. Rech, Matthew P. Goetz

20.09.2019 | Letter to the Editor | Ausgabe 1/2020

Risk-reducing mastectomy in BRCA carriers: survival is not the issue

P. Neven, K. Punie, H. Wildiers, N. Willers, C. Van Ongeval, G. Van Buggenhout, E. Legius

06.11.2019 | Rebuttal Letter | Ausgabe 1/2020

Risk-reducing mastectomy in BRCA mutation carriers: survival is one of the issues—author's reply

Bernadette Anna Maria Heemskerk-Gerritsen, Maartje Joanneke Hooning

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.